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Abstract
A 68-year-old man presented to the Emergency Department with undifferentiated shock. During the three days prior,
he experienced a non-speciﬁc viral-like illness. On examination his blood pressure was 70/40 mm Hg with cool, clammy,
and mottled extremities and ﬂat neck veins. Laboratory investigations revealed a positive inﬂuenza B screen alongside
elevated hemoglobin and hematocrit. Following aggressive ﬂuid resuscitation his blood pressure had marginally
improved and he was transferred to the intensive care unit (ICU). Vasopressor support with cautious ﬂuid resuscitation
continued and at 7- and 10-h following presentation, serum albumin levels were extremely low. Idiopathic systemic
capillary leak syndrome triggered by inﬂuenza B infection was diagnosed. Following a 9-day ICU stay the patient made
a complete recovery and remains stable on intravenous immunoglobulin therapy. This case highlights the importance
judicious ﬂuid resuscitation and serum albumin levels when confronted with refractory shock.
Keywords: Idiopathic systemic capillary leak syndrome, Inﬂuenza B, Shock, Resuscitation

1. Introduction

I

diopathic Systemic Capillary Leak Syndrome
(ISCLS) or Clarkson's Disease, is extremely rare
with the hallmark of spontaneous sudden episodes
of generalized edema alongside the triad of hypotension, hemoconcentration, and hypoalbuminemia
without albuminuria.1 Fewer than 260 cases have
been reported in the literature.2 The classic presentation is an attack of refractory distributive
shock. Attacks of ISCLS are characterized by three
phases: a prodromal phase, a leak phase with
increased capillary permeability, rapid extravasation of plasma and proteins, and subsequently
massive “third-spacing”, and a post-leak or recovery
phase.2,3 The causes of ISCLS remain unknown but

it has been associated with monoclonal gammopathy of unknown signiﬁcance (MGUS).3 ISCLS
diagnosis is challenging, therefore a high degree of
clinical suspicion is warranted.4 Severe presentation, and delays in appropriate therapy are associated with increased mortality.4 We herein report a
case of a 68-year-old patient who was admitted to
our intensive care unit (ICU) with an extreme refractory vasodilatory shock following inﬂuenza B
infection.

2. Case description
A 68-year-old male presented to the Emergency
Department (ED) with undifferentiated shock
and hypotension. He complained of a 3-day history
of
generalized
weakness,
scratchy
throat,
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lightheadedness, and headache. In addition to
vague chest discomfort, he reported diffuse
abdominal pain and nausea without vomiting. He
had intermittent back pain in the weeks prior and
denied any other symptoms. He was a former
smoker with a medical history of COPD, peptic
ulcer disease with perforation, and two admissions
in the preceding two years for low blood pressure
(BP) and polycythemia attributed to dehydration.
His only daily medication was a multivitamin. On
clinical examination in the ED he was afebrile,
eupneic, tachycardiac, and hypotensive (58/26 mm
Hg) with a normal oxygen saturation. His neck veins
were ﬂat, and his extremities were cold, clammy,
and mottled.
Blood and urine specimens were sent for cultures
and respiratory virus nucleic acid testing (NAT) was
ordered. Aggressive ﬂuid resuscitation with crystalloids was initiated alongside broad-spectrum
antibiotics. Electrocardiogram revealed sinus
tachycardia. Contrast-enhanced computed tomography scan of the Thorax, Abdomen and Pelvis was
unrevealing. Urinalysis was normal. Stat laboratory
examination revealed lactic acidosis (3.3 mmol/L),
neutrophilic leukocytosis (19,300 cell/ml), elevated
hemoglobin (14.09 mmol/L) and hematocrit (68.3%),
and a normal platelet count. Electrolytes were unremarkable other than low serum bicarbonate
(15 mmol/L) and calcium (1.62 mmol/L). Blood urea
nitrogen and serum creatinine were slightly
elevated (10.71 mmol/L and 168 mmoL/l, respectively) as was serum cortisol (1241.55 nmol/L).
Coagulation panel and liver function tests were
normal; serum albumin was not sent. Serum tryptase level was normal. After the initial hour of ﬂuid
resuscitation with 6 L normal saline, his BP
remained low and norepinephrine was commenced.
NAT resulted positive for inﬂuenza B and he was
transferred to the ICU.
Upon arrival to the ICU, he remained hypotensive
(BP 82/60 mm Hg) and oliguric. Focused bedside
echocardiogram showed a small pericardial effusion, hyperdynamic ventricles with normal ejection
fraction, and a >50% collapsible inferior vena cava.
Additional crystalloid resuscitation with 4 L of
lactated ringer's was performed over the next
several hours. Despite adequate ﬂuid resuscitation,
increasing norepinephrine requirements necessitated the addition of vasopressin.
Owing to refractory hypotension the differential
diagnosis at this time included undifferentiated shock,
and adrenal insufﬁciency; in addition, leukocytosis
and hemoconcentration gave credence to systemic
mastocytosis, stress-induced secondary polycythemia
(Gaisbock's syndrome) or a myeloproliferative

disorder. During a prior admission for hypotension
JAK2 mutation testing was negative, ruling out polycythemia vera. Over the subsequent hours repeat
testing resulted in consistently elevated hemoglobin
and a progressive lactic acidosis (6.3 mmol/L). We had
a high clinical suspicion for ISCLS, and therefore we
checked serum albumin at hours 7 and 10 after ICU
admission and found it to be extremely low (7 g/L and
4 g/L, respectively). This conﬁrmed the diagnosis of
ISCLS.
Late during the ﬁrst evening of ICU stay a chest xray was ordered due to worsening hypoxia and
revealed bilateral pleural effusions. The patient was
intubated and mechanically ventilated. On day 2,
the patient's serum albumin had increased (30 g/L),
hypotension had resolved, and vasopressor support
was withdrawn. Cultures reported negative and
antibiotics were discontinued. The following day
Hematology was consulted and montelukast was
given, alongside a recommendation for maintenance therapy with intravenous immunoglobin
(IVIG) following discharge. Bilateral chest tubes
were placed to aid in resolution of pleural effusions.
Over the following week the patient developed
acute kidney injury due to a combination of prolonged hypotension, mild rhabdomyolysis and
contrast nephropathy, however renal replacement
therapy was not required. A tracheostomy tube was
placed on day 9 of hospitalization and the patient
was transferred to a rehabilitation unit for eventual
ventilator weaning. He was decannulated as an
outpatient and continues to do well on low-dose
monthly IVIG therapy 8 years after this presentation
(Fig. 1).

3. Discussion
Idiopathic Systemic Capillary Leak Syndrome is a
rare condition. According to the latest literature,2e5
fewer than 260 cases of ISCLS have been reported
since the original description by Clarkson et al., in
1960.1 The syndrome typically affects patients older
than 50 years, and has a slight male-to-female predominance of 1.4:1.6,7 ISCLS is deﬁned as the cyclic
triad of hypotension, hemoconcentration, and
hypoalbuminemia without albuminuria in the
absence of a secondary cause, and progresses
through three phases: prodromal, leak, and postleak or recovery phase.1,3e5 The prodromal phase
has non-speciﬁc symptoms mimicking a viral illness
and lasts between 1 and 5 days.2 Nearly 90% of
patients report fatigue, 50% complain of myalgia
and ﬂulike symptoms, and 30% have a scratchy
throat.4 The leak phase begins and progresses
abruptly to refractory shock over the course of hours
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Fig. 1. The clinical course of our patient who presented to the emergency department at the beginning of the leak phase. Abbreviations: Abs; antibiotics, AKI; acute kidney injury, AVP; vasopressin, BCx; bacterial cultures, CXR; chest x-ray, D/C; discontinued, ED; emergency department, Hb;
hemoglobin, Hct; hematocrit, Hem/Onc; hematology consult, ICU; intensive care unit, IVIG; intravenous immunoglobulin, JAK2; Janus Kinase 2, Lac;
lactate, LR; lactated ringers, MKST; montelukast, MV; mechanical ventilation, NAT; nucleic acid test, NE; norepinephrine, NS; normal saline,
POCUS; point-of-care ultrasound, Rbdo; rhabdomyolysis, SBP; systolic blood pressure, TRF; transfer, WBC; white blood cells.

and lasts 24e72 h.3 Extravasation of up to 70% of
total plasma volume causes profound distributive
shock.3,8 This phase is characterized by the classic
diagnostic triad of the “3 Hs”: hypotension
(<90 mmHg systolic), hemoconcentration (hematocrit >49% in males and >43% in females), and
hypoalbuminemia (<3.0 g/dL) without albuminuria.5 Additional laboratory ﬁndings, seen in over
85% of patients, include leukocytosis and polycythemia.2 Edema, although seen in more than 50%
of patients during the recovery phase, may be mild
initially, and is often not useful for diagnosis.2,5
Between 68 and 76% of adult patients may have an
underlying MGUS, most commonly immunoglobulin kappa.2,4,5 Our patient did not have MGUS, and
in the absence of a pathognomonic biomarker,
ISCLS remains a clinical diagnosis. Such a constellation of ﬁndings during the leak phase makes
diagnosing an initial ISCLS attack challenging.
Indeed, the most common misdiagnoses include
hypovolemic septic shock, polycythemia vera, and
angioedema.2 Anaphylaxis should also be deﬁnitively ruled out with serum tryptase levels.3 The leak
phase may be complicated by compartment syndrome, rhabdomyolysis, and acute renal failure in

20%, 36%, and 57% of cases, respectively.4 The postleak or recovery phase begins with the rapid
remobilization of ﬂuids back into circulation and
diuresis, and lasts from 48 h to more than one
week.3 Alongside the resolution of shock, this phase
may be complicated by severe pulmonary edema
and cardiovascular overload.3 Most fatal outcomes
from ISCLS occur during this phase due to overzealous initial ﬂuid resuscitation.3,6,9 Overall the
condition remains underrecognized and is fatal in
30e75% of cases.3,10
Our patient presented at the verge of the leak
phase, just after a typical course of prodromal
symptoms. The mainstay of treatment during this
phase is supportive care and judicious ﬂuid
replacement in the ICU. Fluid overload should be
avoided as it is associated with a higher mortality
during the recovery phase.6,9 The choice of ﬂuids
remains somewhat controversial. Owning to profound hypoalbuminemia, colloid solutions have
been proposed in addition to crystalloids.3 Proteins
like albumin, which has a molecular weight
<200 kDa extravasate into the interstitial space
during the leak phase of ISCLS and may not be
effective.11 As we did not have a deﬁnitive diagnosis
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during the leak phase, our patient was initially stabilized using crystalloids without colloids. According to a report in two ISCLS patients, hemodynamic
stabilization can be achieved during the leak phase
with 10% pentastarch infusion, due to its greater
molecular weight.12 Disease speciﬁc treatment remains elusive. Pharmacologic agents targeted at
reducing capillary permeability and histamine
release such as terbutaline, theophylline, and montelukast have demonstrated sporadic success.4,13
Our therapeutic decisions were anchored to the
presumed pathogenesis of ISCLS, namely leukotriene enhanced capillary leakage coupled with
immune-complex mediated cytokine release and
complement activation.14,15 Indeed, the initiation of
montelukast followed by maintenance IVIG has
been shown to be beneﬁcial in previous reports.16
The trigger of an ISCLS attack is important for the
clinician to recognize as it may hint towards the
diagnosis during the initial resuscitation. Triggers
may include surgical interventions, malignancies,
medications, and viral infections.3,17e19 Inﬂuenza A
is perhaps the most common viral ISCLS trigger,
yet less than a handful of cases have been
reported.20e22 To the best of our knowledge this is
the ﬁrst report of inﬂuenza B precipitating an ISCLS
attack. The exact mechanisms remain ill-deﬁned;
however, it is suggested that T-cell activation in
response to inﬂuenza and other viruses increases
the production of pro-inﬂammatory cytokines and
complement activating proteins, which, coupled to
an MGUS paraprotein induce immunopathological
damage of the endothelial barrier. Which inﬂuenza
epitopes trigger ISCLS are yet to be determined as
so few cases have been reported.21 Although it may
be presumed that our patient had milder attacks in
the two years prior to this presentation, it is unproven that inﬂuenza B was the trigger in those
instances. A single report of ISCLS attack following
seasonal inﬂuenza vaccination has been published,23 and this may also be an explanation for our
patient's prior episodes. The protective effects of
IVIG wean once it is discontinued leading to ISCLS
ﬂares.24 Scattered reports have determined that
low-dose (0.4e2 g/kg) monthly IVIG decreases the
incidence of such attacks by as much as 89%, and
has thus become the standard of care.25 Furthermore, as the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been
reported as a trigger,19,26 and it remains unclear
whether vaccines against this virus may also induce
ISCLS, there is no plan to stop monthly IVIG therapy in our patient. Indeed, our patient was advised
and received both inﬂuenza and SARS-CoV-2 vaccines without adverse events.

4. Conclusion
This case highlights the importance of obtaining
serum albumin levels when initially confronted with
refractory distributive shock. When albumin is unavailable, maintaining a high degree of clinical
suspicion for ISCLS with possible triggers in mind,
may help to guide a judicious ﬂuid resuscitation.
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